What happened with DRIO today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
DarioHealth Corp. helps employers and health plans provide employees and members with health-management programs through mobile apps and websites. Its programs combine connected health devices, personalized guidance and coaching to support needs such as diabetes, high blood pressure, behavioral health and muscle and joint conditions. Partner providers add virtual clinical care. Customers can buy individual programs or combine several under one contract instead of buying separate services.
Business customers—including employers, health plans and pharmaceutical companies—provide most of its revenue. They pay monthly subscriptions based on the number of covered members, members actively using the service, or a combination of the two. DarioHealth also sells digital health products and connected devices directly to consumers, who pay out of pocket.
Revenue depends on eligible people enrolling and using the programs, and on customers renewing their contracts. Some agreements tie payment to health outcomes or minimum usage, so missed targets can require refunds or fee reductions. Its medical devices can be marketed only in jurisdictions where they have regulatory authorization.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Omada Health competes with DarioHealth for employers and health plans paying for digital diabetes, hypertension and musculoskeletal care for their members. Watch Omada’s wins with these buyers: they show where Dario faces competition across both cardiometabolic and musculoskeletal programs.
Teladoc Health competes with DarioHealth for employers and health plans buying integrated virtual care for chronic conditions and behavioral health. Its Integrated Care business—not consumer-focused BetterHelp—is the part to watch for competition as Dario brings multiple health programs onto one platform.
Hinge Health competes with DarioHealth to sell digital musculoskeletal care to employers that pay their employees’ medical costs themselves and to health plans. Watch its client contracts: Hinge is most often the sole digital musculoskeletal provider for covered members, limiting Dario’s opportunity to sell that program to the same buyers.
Hims & Hers Health competes with DarioHealth for consumers seeking digital weight-management and cardiometabolic care, offering online consultations, treatment plans and medications while Dario sells health-management products directly to self-paying consumers. Watch its weight-loss offering for pressure on Dario’s consumer business, rather than its main business-customer base, which accounts for three-fourths of current revenue.
Teladoc Health, Inc. earningsTDOC
Teladoc Health's Integrated Care report will show whether employers and health plans still buy bundled chronic-condition and behavioral-health care, the same enterprise market DarioHealth Corp. is trying to win.
Focus on customer demand and revenue in Teladoc's Integrated Care business, not consumer-focused BetterHelp. Steady or rising demand would show that employers and health plans still pay for bundled virtual care, leaving DarioHealth Corp. room to win or expand contracts. Weakening demand would suggest tighter budgets or less willingness to buy, making Dario's platform sales harder to grow.
Hinge Health, Inc. earningsHNGE
Hinge Health's client contracts will show whether employers and health plans still buy digital musculoskeletal care, and how much competition DarioHealth Corp. faces for those buyers.
Watch Hinge's client contracts and whether it remains the sole digital musculoskeletal provider for covered members. Stable or growing contracts would show that employers and health plans still buy this care, but Hinge's exclusive position limits DarioHealth Corp.'s chance to sell the same program to those buyers. Fewer contracts or a weaker hold on exclusivity could signal softer demand—or more room for Dario.
Omada Health, Inc. earningsOMDA
Omada Health's employer and health-plan results will show whether buyers are purchasing digital diabetes, hypertension, and musculoskeletal care—the same programs DarioHealth Corp. sells, and a direct contest for contracts.
Watch Omada's employer and health-plan wins and growth, especially in diabetes, hypertension, and musculoskeletal programs. More wins would confirm that buyers are funding these digital-care offerings, but Omada may also take contracts DarioHealth Corp. could have pursued. Fewer wins could mean weaker buyer demand or tougher competition for both companies.
Hims & Hers Health, Inc. earningsHIMS
Hims & Hers Health's weight-management results will show how self-paying consumers respond to online cardiometabolic care, a signal of competition for DarioHealth Corp.'s direct-to-consumer business.
Watch Hims & Hers' weight-management business, not as a measure of demand from DarioHealth Corp.'s enterprise customers. Strength would show that self-paying consumers will buy related care online, while sharpening competition for Dario's smaller direct-to-consumer business. Weakness would suggest less pressure through that channel.
DarioHealth Corp. earningsThis company
DarioHealth Corp.'s report will show whether it can turn employer and health-plan programs into more revenue while preserving the gross profit left after serving those customers.
Read revenue alongside gross margin—the share of revenue left after the cost of serving customers. Revenue recovering while gross margin holds or improves would show that employer and health-plan business is growing without service costs taking a larger bite. Weak revenue or a falling margin would point to customer losses, limited member engagement, or costs still weighing on the business. Together, the figures show whether Dario can narrow losses through its platform business rather than rely on more financing.
